304 related articles for article (PubMed ID: 19924018)
1. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
[TBL] [Abstract][Full Text] [Related]
2. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
Nishimori I; Otsuki M
Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
[TBL] [Abstract][Full Text] [Related]
4. Metachronous extrapancreatic lesions in autoimmune pancreatitis.
Takuma K; Kamisawa T; Anjiki H; Egawa N; Igarashi Y
Intern Med; 2010; 49(6):529-33. PubMed ID: 20228586
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune pancreatitis, sclerosing cholangitis, liver inflammatory pseudotumors, retroperitoneal fibrosis, lymphadenopathy, and sialoadenitis in a single patient: a multifaceted expression of a hitherto unrecognized systemic autoimmune syndrome?
de Suray N; Van Beers B; Sempoux C; Borschette C; Lonneux M; Deprez P; Geubel A
Pancreas; 2009 May; 38(4):476-8. PubMed ID: 19390412
[No Abstract] [Full Text] [Related]
6. A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET.
Kawamura E; Habu D; Higashiyama S; Tsushima H; Shimonishi Y; Nakayama Y; Enomoto M; Kawabe J; Tamori A; Kawada N; Shiomi S
Ann Nucl Med; 2007 Jun; 21(4):223-8. PubMed ID: 17581721
[TBL] [Abstract][Full Text] [Related]
7. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
Nakazawa T; Ohara H; Sano H; Ando T; Aoki S; Kobayashi S; Okamoto T; Nomura T; Joh T; Itoh M
Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
[TBL] [Abstract][Full Text] [Related]
8. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
9. Highly active state of autoimmune pancreatitis with mikulicz disease.
Kubota K; Wada T; Kato S; Mozaki Y; Yoneda M; Fujita K; Takahashi H; Inamori M; Abe Y; Kobayashi N; Kirikoshi H; Saito S; Inayama Y; Nakajima A
Pancreas; 2010 Jan; 39(1):e6-10. PubMed ID: 19904224
[TBL] [Abstract][Full Text] [Related]
10. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy.
Kamisawa T; Nakajima H; Egawa N; Funata N; Tsuruta K; Okamoto A
Pancreatology; 2006; 6(1-2):132-7. PubMed ID: 16327291
[TBL] [Abstract][Full Text] [Related]
11. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission.
Miura H; Miyachi Y
JOP; 2009 Jul; 10(4):432-7. PubMed ID: 19581751
[TBL] [Abstract][Full Text] [Related]
12. Abdominal extrapancreatic lesions associated with autoimmune pancreatitis: radiological findings and changes after therapy.
Sohn JH; Byun JH; Yoon SE; Choi EK; Park SH; Kim MH; Lee MG
Eur J Radiol; 2008 Sep; 67(3):497-507. PubMed ID: 17904325
[TBL] [Abstract][Full Text] [Related]
13. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance.
Deshpande V; Gupta R; Sainani N; Sahani DV; Virk R; Ferrone C; Khosroshahi A; Stone JH; Lauwers GY
Am J Surg Pathol; 2011 Jan; 35(1):26-35. PubMed ID: 21164284
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune pancreatitis-related cholecystitis: a morphologically and immunologically distinctive form of lymphoplasmacytic sclerosing cholecystitis.
Wang WL; Farris AB; Lauwers GY; Deshpande V
Histopathology; 2009 Jun; 54(7):829-36. PubMed ID: 19635102
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis.
Umemura T; Zen Y; Hamano H; Kawa S; Nakanuma Y; Kiyosawa K
Hepatology; 2007 Aug; 46(2):463-71. PubMed ID: 17634963
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
[TBL] [Abstract][Full Text] [Related]
18. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.
Uehara T; Hamano H; Kawa S; Sano K; Honda T; Ota H
Pathol Int; 2005 Jul; 55(7):405-11. PubMed ID: 15982215
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune pancreatitis: a systemic immune complex mediated disease.
Deshpande V; Chicano S; Finkelberg D; Selig MK; Mino-Kenudson M; Brugge WR; Colvin RB; Lauwers GY
Am J Surg Pathol; 2006 Dec; 30(12):1537-45. PubMed ID: 17122509
[TBL] [Abstract][Full Text] [Related]
20. IgG4-positive sclerosing cholangitis following autoimmune pancreatitis with deranged CA19.9.
Ong SL; Garcea G; Puls F; Richards C; Mulcahy K; Grant A; Dennison AR; Berry DP
Int J Surg Pathol; 2011 Feb; 19(1):84-7. PubMed ID: 18611930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]